Popular Articles

Eurand Successfully Completes Registration Procedure For Paracetamol ODT 250 And 500 Mg In The European Union
Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced that the Dutch Medicines Evaluation Board (MEB) informed the Company that the Decentralized Procedure (DCP) for registration of Paracetamol 250 and 500 mg Orodispersible Tablets (ODT) in several EU countries has been successfully completed.

Cancer; Not Simply A Question Of Life Or Death, Macmillan Cancer Support
Health and social care services are overlooking the long-term physical and emotional effects of cancer survivors, leaving many of the two million people living with or beyond the disease in the UK suffering alone and in silence. According to Macmillan Cancer Support, cancer survivors are suffering needlessly and in silence: overlooked by health and social care services that frequently miss the long-term physical and emotional effects of the disease.
News of the day
Study Results Present Efficacy And Safety Findings From The PHIRST-1 Study Of Patients With Pulmonary Arterial Hypertension
United Therapeutics Corporation (Nasdaq: UTHR) and Eli Lilly and Company (NYSE: LLY) today announced the results of a pivotal 16-week study showing that a once-daily dose of tadalafil was generally well tolerated, improved exercise capacity and improved time to clinical worsening in patients with pulmonary arterial hypertension (PAH)(1). The randomized, double-blind, 16-week, placebo-controlled Phase 3 study followed 405 patients with PAH, either treatment-naive or taking bosentan, randomized to placebo or tadalafil 2.5 mg, 10 mg, 20 mg or 40 mg orally. Results from the study entitled, "Tadalafil Therapy for Pulmonary Arterial Hypertension," were published in today"s issue of Circulation.
Public Health

Slicing Chromosomes Leads To New Insights Into Cell Division

By using ultrafast laser pulses to slice off pieces of chromosomes and observe how the chromosomes behave, biomedical engineers at the University of Michigan have gained pivotal insights into mitosis, the process of cell division. Their findings could help scientists better understand genetic diseases, aging and cancer. Cells in plants, fungi, and animals including those in the human body divide through mitosis, during which the DNA-containing chromosomes separate between the resulting daughter cells. Forces in a structure called the mitotic spindle guide the replicated chromosomes to opposing sides as one cell eventually becomes two. "Each cell needs the right number of chromosomes. It"s central to life in general and very important in terms of disease," said Alan Hunt, an associate professor in the Department of Biomedical Engineering and an author of a paper describing these findings published in Current Biology. "One of the really important fundamental questions in biology is how do chromosomes get properly segregated when cells divide. What are the forces that move chromosomes around during this process? Where do they come from and what guides the movements?" Hunt"s results validate the theory that "polar ejection forces" are at play. Scientists had hypothesized that the direction and magnitude of these forces might provide physical cues guiding chromosome movements. In this capacity, polar ejection forces would play a central role separating chromosomes in dividing cells, but no one had established a direct link until now. Polar ejection forces are thought to arise out of the interaction between protein motors on the arms of chromosomes that push against cells" microtubules. Microtubules are long, thin tubes that form a central component of the cytoskeleton and the mitotic spindle. They serve as intracellular structural supports and as railways along which molecular motors move cargoes such as chromosomes. Hunt"s group hypothesized that polar ejection forces should be proportional to the chromosome"s size, and therefore could be predictably changed by altering the size of the chromosomes. Using newts as a model organism, they cut off pieces of the chromosomes" arms. "We asked what the relationship is between the size of the fragment we removed and the direction the chromosome moved," Hunt said. "Not only did we observe a relationship, we established that polar ejection forces were in fact a direct cue that guided chromosomal movements in mitosis." To achieve this, Hunt performed "nanoscale surgery," as he calls it, taking advantage of the unprecedented precision of femtosecond pulses of laser light. A femtosecond is one billionth of one millionth of a second. The chromosomes he altered were only micrometers long, and the slices across the chromosomes were only nanometers thick. A nanometer is one-billionth of a meter, about a million times thinner than a human hair. Understanding how chromosome guidance occurs allows scientists to determine how failures lead to genetic diseases, aging and cancer. When cells don"t properly divide, they usually die. But survival can cause cancer or aging-related disorders. Likewise, genetic diseases such as Down"s syndrome result from improper chromosome segregation. Mitosis, Hunt says, is one of the most important targets of chemotherapy. "By knowing how chromosomes move, we can better understand how these drugs interfere with those movements and we can design experiments to screen for new drugs," Hunt said. "It will also allow us to have a better handle on what makes these drugs work. There are a lot of drugs that interfere with mitosis, but only a few are good for cancer therapy." The paper is called, "The Distribution of Polar Ejection Forces Determines the Amplitude of Chromosome Directional Instability." It is published in the May 26 print edition of Current Biology. This research is funded by the National Science Foundation, the National Institutes of Health and the Cellular Biotechnology Training Grant at the University of Michigan. Hunt is also an assistant research scientist in the U-M Institute of Gerontology, and director of the Biomedical Lab at the Center for Ultrafast Optical Sciences. Michigan Engineering: The University of Michigan College of Engineering is ranked among the top engineering schools in the country. At more than $130 million annually, its engineering research budget is one of largest of any public university. Michigan Engineering is home to 11 academic departments and a National Science Foundation Engineering Research Center. The college plays a leading role in the Michigan Memorial Phoenix Energy Institute and hosts the world class Lurie Nanofabrication Facility. Michigan Engineering"s premier scholarship, international scale and multidisciplinary scope combine to create The Michigan Difference. University of Michigan


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):